134 related articles for article (PubMed ID: 8923458)
1. Overexpression of membrane glycoprotein PC-1 in MDA-MB231 breast cancer cells is associated with inhibition of insulin receptor tyrosine kinase activity.
Belfiore A; Costantino A; Frasca F; Pandini G; Mineo R; Vigneri P; Maddux B; Goldfine ID; Vigneri R
Mol Endocrinol; 1996 Nov; 10(11):1318-26. PubMed ID: 8923458
[TBL] [Abstract][Full Text] [Related]
2. Insulin-resistant MDA-MB231 human breast cancer cells contain a tyrosine kinase inhibiting activity.
Costantino A; Milazzo G; Giorgino F; Russo P; Goldfine ID; Vigneri R; Belfiore A
Mol Endocrinol; 1993 Dec; 7(12):1667-76. PubMed ID: 8145772
[TBL] [Abstract][Full Text] [Related]
3. Membrane glycoprotein PC-1 and insulin resistance in non-insulin-dependent diabetes mellitus.
Maddux BA; Sbraccia P; Kumakura S; Sasson S; Youngren J; Fisher A; Spencer S; Grupe A; Henzel W; Stewart TA
Nature; 1995 Feb; 373(6513):448-51. PubMed ID: 7830796
[TBL] [Abstract][Full Text] [Related]
4. Membrane glycoprotein PC-1 inhibition of insulin receptor function occurs via direct interaction with the receptor alpha-subunit.
Maddux BA; Goldfine ID
Diabetes; 2000 Jan; 49(1):13-9. PubMed ID: 10615944
[TBL] [Abstract][Full Text] [Related]
5. Decreased insulin receptor tyrosine kinase activity and plasma cell membrane glycoprotein-1 overexpression in skeletal muscle from obese women with gestational diabetes mellitus (GDM): evidence for increased serine/threonine phosphorylation in pregnancy and GDM.
Shao J; Catalano PM; Yamashita H; Ruyter I; Smith S; Youngren J; Friedman JE
Diabetes; 2000 Apr; 49(4):603-10. PubMed ID: 10871198
[TBL] [Abstract][Full Text] [Related]
6. The Q allele variant (GLN121) of membrane glycoprotein PC-1 interacts with the insulin receptor and inhibits insulin signaling more effectively than the common K allele variant (LYS121).
Costanzo BV; Trischitta V; Di Paola R; Spampinato D; Pizzuti A; Vigneri R; Frittitta L
Diabetes; 2001 Apr; 50(4):831-6. PubMed ID: 11289049
[TBL] [Abstract][Full Text] [Related]
7. Elevated plasma cell membrane glycoprotein levels and diminished insulin receptor autophosphorylation in obese, insulin-resistant rhesus monkeys.
Pender C; Ortmeyer HK; Hansen BC; Goldfine ID; Youngren JF
Metabolism; 2002 Apr; 51(4):465-70. PubMed ID: 11912555
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-1 blocks insulin and insulin-like growth factor-stimulated growth in MCF-7 human breast cancer cells by inhibiting receptor tyrosine kinase activity.
Costantino A; Vinci C; Mineo R; Frasca F; Pandini G; Milazzo G; Vigneri R; Belfiore A
Endocrinology; 1996 Oct; 137(10):4100-7. PubMed ID: 8828463
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of membrane glycoprotein PC-1 can influence insulin action at a post-receptor site.
Kumakura S; Maddux BA; Sung CK
J Cell Biochem; 1998 Mar; 68(3):366-77. PubMed ID: 9518262
[TBL] [Abstract][Full Text] [Related]
10. Expression of the putative inhibitor of the insulin receptor tyrosine kinase PC-1 in dermal fibroblasts from patients with syndromes of severe insulin resistance.
Whitehead JP; Humphreys PJ; Dib K; Goding JW; O'Rahilly S
Clin Endocrinol (Oxf); 1997 Jul; 47(1):65-70. PubMed ID: 9302374
[TBL] [Abstract][Full Text] [Related]
11. PC-1 content in skeletal muscle of non-obese, non-diabetic subjects: relationship to insulin receptor tyrosine kinase and whole body insulin sensitivity.
Frittitta L; Youngren J; Vigneri R; Maddux BA; Trischitta V; Goldfine ID
Diabetologia; 1996 Oct; 39(10):1190-5. PubMed ID: 8897006
[TBL] [Abstract][Full Text] [Related]
12. Elevated PC-1 content in cultured skin fibroblasts correlates with decreased in vivo and in vitro insulin action in nondiabetic subjects: evidence that PC-1 may be an intrinsic factor in impaired insulin receptor signaling.
Frittitta L; Spampinato D; Solini A; Nosadini R; Goldfine ID; Vigneri R; Trischitta V
Diabetes; 1998 Jul; 47(7):1095-100. PubMed ID: 9648833
[TBL] [Abstract][Full Text] [Related]
13. Role of PC-1 in the etiology of insulin resistance.
Goldfine ID; Maddux BA; Youngren JF; Trischitta V; Frittitta L
Ann N Y Acad Sci; 1999 Nov; 892():204-22. PubMed ID: 10842664
[TBL] [Abstract][Full Text] [Related]
14. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E
Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of insulin receptor phosphorylation by PC-1 is not mediated by the hydrolysis of adenosine triphosphate or the generation of adenosine.
Grupe A; Alleman J; Goldfine ID; Sadick M; Stewart TA
J Biol Chem; 1995 Sep; 270(38):22085-8. PubMed ID: 7673181
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of breast cancer cell growth in vitro by a tyrosine kinase inhibitor.
Reddy KB; Mangold GL; Tandon AK; Yoneda T; Mundy GR; Zilberstein A; Osborne CK
Cancer Res; 1992 Jul; 52(13):3636-41. PubMed ID: 1617636
[TBL] [Abstract][Full Text] [Related]
17. Insulin modulates PC-1 processing and recruitment in cultured human cells.
Menzaghi C; Di Paola R; Baj G; Funaro A; Arnulfo A; Ercolino T; Surico N; Malavasi F; Trischitta V
Am J Physiol Endocrinol Metab; 2003 Mar; 284(3):E514-20. PubMed ID: 12441313
[TBL] [Abstract][Full Text] [Related]
18. The role of membrane glycoprotein plasma cell antigen 1/ectonucleotide pyrophosphatase phosphodiesterase 1 in the pathogenesis of insulin resistance and related abnormalities.
Goldfine ID; Maddux BA; Youngren JF; Reaven G; Accili D; Trischitta V; Vigneri R; Frittitta L
Endocr Rev; 2008 Feb; 29(1):62-75. PubMed ID: 18199690
[TBL] [Abstract][Full Text] [Related]
19. Membrane glycoprotein PC-1 and insulin resistance.
Goldfine ID; Maddux BA; Youngren JF; Frittitta L; Trischitta V; Dohm GL
Mol Cell Biochem; 1998 May; 182(1-2):177-84. PubMed ID: 9609127
[TBL] [Abstract][Full Text] [Related]
20. Functional trans-inactivation of insulin receptor kinase by growth-inhibitory angiotensin II AT2 receptor.
Elbaz N; Bedecs K; Masson M; Sutren M; Strosberg AD; Nahmias C
Mol Endocrinol; 2000 Jun; 14(6):795-804. PubMed ID: 10847582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
